Letters to the Editor

Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker

Leumit Health Services
Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv; Faculty of Medicine, Tel-Aviv University; Tel-Aviv
Faculty of Medicine, Tel-Aviv University; Tel-Aviv; Israel; Department of Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv
Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv; Faculty of Medicine, Tel-Aviv University; Tel-Aviv
Hadassah Medical Center, Jerusalem; Israel; Hebrew University, Jerusalem
Department of Hematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv; Faculty of Medicine, Tel-Aviv University; Tel-Aviv
Leumit Health Services, Israel; Ariel University
Haematologica Early view Jan 29, 2026 https://doi.org/10.3324/haematol.2025.300022